In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 9, 1996, Pages 2117-2120

  Alcaide, Fernando ^a   Carratala, Jordi ^a   Liñares, Josefina ^a   Gudiol, Francesc ^a   Martin, Rogelio ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DIRITHROMYCIN; ERYTHROMYCIN; JOSAMYCIN; MACROLIDE; MIDECAMYCIN; ROXITHROMYCIN; SPIRAMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CANCER PATIENT; CROSS RESISTANCE; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS MITIS;

EID: 0029821110     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.9.2117     Document Type: Article

References (34)

1. Alcaide, F, J. Carratalà, J. Liñares, F. Gudiol, and R. Martín. 1995. In vitro activity of eight macrolide antibiotics and RP-59500 against viridans streptococci isolated from blood of neutropenic cancer patients, abstr. E51, p. 94. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
2. Alcaide, F., J. Liñares, R. Pallares, J. Carratalà, M. A. Benitez, F. Gudiol, and R. Martín. 1995. In vitro activities of 22 β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob. Agents Chemother. 39:2243-2247.
3. Awada, A., P. Van der Auwera, P. Meunier, D. Daneau, and J. Klaslersky. 1992. Streptococcal and enterococcal bacteremia in patients with cancer. Clin. Infect. Dis. 15:33-48.
4. Barry, A. L., and P. C. Fuchs. 1995. In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens. Antimicrob. Agents Chemother. 39:238-240.
5. Bochud, P. Y., P. H. Egglman, T. H. Calandra, G. Van Melle, L. Saghafi, and P. Francioli. 1994. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin. Infect. Dis. 18:25-31.
6. Burden, A. D., B. A. Oppenheim, D. Crowther, A, Howell, G. R, Morgenstern, J. H. Scarffe, and N. Thatcher. 1991. Viridans Streptococcal bacteraemia in patients with haematological and solid malignancies. Eur. J. Cancer 27:409-411.
7. Carratalà, J., F. Alcaide, A. Fernández-Sevilla, X. Corbella, J. Liñares, and F. Gudiol. 1995. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin. Infect. Dis. 20:1169-1173.
8. Carratalà, J., and F. Gudiol. 1995. Life-threatening infections due to penicillin-resistant viridans streptococci. Curr. Opin. Infect. Dis. 8:123-126.
9. Coykendall, A. L. 1989. Classification and identification of the viridans streptococci. Clin. Microbiol. Rev. 2:315-328.
10. Devaux, Y., E. Archimbaud, D. Guyotat, C. Plotton, J. Maupas, J. Fleurette, and D. Fiere. 1992. Streptococcal bacteremia in neutropenic adult patients. Nouv. Rev. Fr. Hematol. 34:191-195.
11. Dybedal, I., and J. Lamkvik. 1989. Respiratory insufficiency in acute leukemia following treatment with cytosine arabinoside and septicemia with Streptococcus viridans. Eur. J. Haematol. 42:405-406. (Letter.)
12. Elting, L. S., G. P. Bodey, and B. H. Keefe. 1992. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin. Infect. Dis. 14:1201-1207.
13. Facklam, R. R., and J. A. Washington II. 1991. Streptococcus and related catalase-negative gram-positive cocci, p. 238-257. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.). Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
14. Guiot, H. F. L., W. G. Peters, P. J. van den Broek, J. W. M. van der Meer, J. A. Kramps, R. Willemze, and R. van Furth. 1990. Respiratory failure elicited by streptococcal septicemia in patients treated with cytosine arabinoside, and its prevention by penicillin. Infection 18:131-137.
15. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. 1994. Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin. JAMA 272:1183-1189.
16. Johnson, C. C., L. Slavoski, M. Schwartz, P. May, P. G. Pitsakis, A. L. Shur, and M. E. Levison. 1995. In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and enterococci. Diagn. Microbiol. Infect. Dis. 21:169-173.
17. Kern, W. V., B. Hay, P. Kern, R. Marre, and R. Arnold. 1994. A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. Antimicrob. Agents Chemother. 38:465-472.
18. Kremery, V., and J. Trupl. 1995. Bacteraemia due to penicillin-resistant Streptococcus viridans in cancer patients, before and after prophylaxis with penicillin. Lancet 346:1362-1363. (Letter.)
19. McWhinney, P. H., S. H. Gillespie, C. C. Kibbler, A. V. Hoffbrand, and H. G. Prentice. 1991. Streptococcus mitis and ARDS in neutropenic patients. Lancet 337:429. (Letter.)
20. McWhinney, P. H. M., S. Patel, R. A. Whiley, J. M. Hardie, S. H. Gillespie, and C. C. Kibbler. 1993. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob. Agents Chemother. 37:2493-2495.
21. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
22. National Committee for Clinical Laboratory Standards. 1995. Performance standards for antimicrobial susceptibility testing: sixth informational supplement. M100-S6/M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
23. Rolston, K. V. I., L. S. Elting, and G. P. Bodey. 1995. Baeteremia due to viridans streptococci in neutropenic patients. Am. J. Med. 99:450. (Letter.)
24. Rozenberg-Arska, M., A. Dekker, L. Verdonck, and J. Verhoef. 1989. Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin. Infection 17:240-244.
25. Ruoff, K. L. 1995. Streptococcus. p. 299-307. In P. R. Murray, E. J. Baron. M. A. Pfaller, F. C. Tenover, and R. U. Yolken (ed.). Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
26. Santini, C., M. Venditti, P. Baiocchi, C. Brandimarte, P. Serra, F. Mandelli, C. Girmenia, A. Micozzi, and P. Martino. 1988. Emergence of penicillin-resistant viridans streptococci causing septicemia in gianulocytopenic patients. Bur. J. Epidemiol. 4:391-392. (Letter.)
27. Shonekan, D., S. Handwerger, and D. Mildvan. 1995. Comparative in vitro activities of RP59500 (quinupristin/dalfopristin). CL 329,988, CL 331,002, CP-99,219, clinafloxacin, teicoplanin and vancomycin against gram-positive bacteria, abstr. E124, p. 107. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
28. Sotiropoulos, S. V., M. A. Jackson, G. M. Woods, R. A. Hicks, J. Cullen, and A. I. Freeman. 1989. Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr. Infect. Dis. J. 8:755-758.
29. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1992. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, Win 57273, ofloxacin, and ciprofloxacin. Antimicrob. Agents Chemother. 36:856-859.
30. Steiner, M., J. Villablanca, J. Kersey, et al. 1933. Viridans streptococcal shock in bone marrow transplantation patients. Am. J. Hematol. 42:354-358.
31. Tarasi, A., and A. Tomasz. 1995. Activity of RP59500 against multidrug resistant clones of Streptococcus pneumoniae, abstr. E116, p. 106. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
32. Venditti, M., P. Baiocchi, C. Santini, C. Brandimarte, P. Sierra, C. Gentile, C. Girmenia, and P. Martino. 1989. Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients. Antimicrob. Agents Chemother. 33:580-582.
33. Weisman, S. J., F. J. Scoopo, G. M. Johnson, A. J. Altman, and J. J. Quinn. 1990. Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections. J. Clin. Oncol. 8:453-459.
34. Wimperis, J. Z., T. P. Baglin, R. E. Marcus, and R. E. Warren. 1991. An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts. Bone Marrow Transplant. 8:363-367.